Treatment of rheumatoid arthritis patients with anti-TNF-alpha monoclonal antibody is accompanied by down-regulation of the activating Fcgamma receptor I on monocytes.

Wijngaarden, S.; van de Winkel, J.G.J.; Bijlsma, J.W.J.; Lafeber, F.P.J.G.; van Roon, J.A.G.

Treatment of rheumatoid arthritis patients with anti-TNF-alpha monoclonal antibody is accompanied by down-regulation of the activating Fcgamma receptor I on monocytes.

DSpace/Manakin Repository

Treatment of rheumatoid arthritis patients with anti-TNF-alpha monoclonal antibody is accompanied by down-regulation of the activating Fcgamma receptor I on monocytes.

Wijngaarden, S.; van de Winkel, J.G.J.; Bijlsma, J.W.J.; Lafeber, F.P.J.G.; van Roon, J.A.G.

(2008) Clinical and Experimental Rheumatology, volume 26, issue 1, pp. 89 - 95

(Article)

Download/Full Text

Open Access version via Utrecht University Repository

Publisher version

ISSN: 0392-856X

Publisher: Clinical and Experimental Rheumatology S.A.S.

(Peer reviewed)

See more statistics about this item